Glaxosmithkline has agreed to pay more than $US1 billion ($1.14 billion) to resolve more than 800 cases alleging its Paxil antidepressant - sold in Australia as Aropax - caused birth defects in some users' children, according to people familiar with the settlements.
via smh.com.au
1 comment:
Another class action law suit lost by a Pharma company..
Post a Comment